Skip to main content

Logo 50 Pill - purple oval

Pill with imprint Logo 50 is Purple, Oval and has been identified as Carbidopa and Levodopa Extended-Release 25 mg / 100 mg. It is supplied by Advagen Pharma Ltd.

Carbidopa/levodopa is used in the treatment of Parkinson's Disease; Neuroleptic Malignant Syndrome; GTP-CH Deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo 50

Carbidopa and Levodopa Extended-Release

Imprint
Logo 50
Strength
25 mg / 100 mg
Color
Purple (light purple to purple, dappled)
Shape
Oval (uncoated)
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Advagen Pharma Ltd.
Manufacturer
Rubicon Research Pvt Ltd.
National Drug Code (NDC)
72888-0155

Get help with Imprint Code FAQs.

Related images for "Logo 50"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.